A new Pb(II)-based coordination polymer constructed by 5-((4-carboxyphenoxy)methyl)benzene-1,3-dioic acid and N-donor co-ligand: crystal structure and anti-glioma activity

Abstract A new lead(II)-organic architecture [Pb(HL) (dipyrido[3,2-a:2′,3′-c]phenazine (dppz))](H2O)2 (1) was successfully prepared under hydrothermal conditions by using organic-acid linker 5-((4-carboxyphenoxy)methyl) benzene-1,3-dioic acid (H3L) and N-donor chelating ligand dppz. The as-prepared complex was characterized by single-crystal X-ray structural analysis, powder X-ray diffraction (PXRD), and elemental analyses, which reveals that complex 1 shows a one-dimensional (1D) chain-like structure that is further extended to the 3D supermolecular network through H-bond and π-π interactions. Complex 1 was transformed to the nanoscale regime (ca. 190 nm) by mechanical grinding to yield the nano-1, maintaining its structure and crystallinity. Furthermore, the anticancer activity of the nano-1 toward the human neuroglioma cells (U251, U87, SHG-44, and A172) was evaluated via the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay.

[1]  Jiangtao Li,et al.  A luminescent porous metal–organic framework with Lewis basic pyridyl sites as a fluorescent chemosensor for TNP detection , 2018 .

[2]  Xiao Ji,et al.  Two new inorganic anions directed Zn(II)-tetrazole frameworks: Syntheses, structures and photoluminescent properties , 2017 .

[3]  Jing Li,et al.  Microporous metal–organic framework with 1D helical chain building units: Synthesis, structure and gas sorption properties , 2017 .

[4]  Rui‐Biao Lin,et al.  Unique (3,9)-connected porous coordination polymers constructed by tripodal ligands with bent arms , 2016 .

[5]  Guanghua Li,et al.  Three Metal–Organic Frameworks Based on Binodal Inorganic Building Units and Hetero-O, N Donor Ligand: Solvothermal Syntheses, Structures, and Gas Sorption Properties , 2015 .

[6]  Yun-Hu Han,et al.  Chiral template induced homochiral MOFs built from achiral components: SHG enhancement and enantioselective sensing of chiral alkamines by ion-exchange. , 2015, Chemical communications.

[7]  L. Armelao,et al.  Exploiting dimensional variability in coordination polymers: solvent promotes reversible conversion between 3D and chiral 1D architectures. , 2015, Chemical communications.

[8]  Wang Zhao,et al.  A 3-D metal–organic framework with a rutile topology network, right- or left- handed helical chains and tunable UV-to-visible photoluminescence , 2015 .

[9]  Wei Zhang,et al.  Supramolecular self-assembled nanoparticles for chemo-photodynamic dual therapy against cisplatin resistant cancer cells. , 2015, Chemical communications.

[10]  P. Tchounwou,et al.  Cisplatin in cancer therapy: molecular mechanisms of action. , 2014, European journal of pharmacology.

[11]  R. Banerjee,et al.  Mechanical downsizing of a gadolinium(III)-based metal-organic framework for anticancer drug delivery. , 2014, Chemistry.

[12]  Paresh Chandra Ray,et al.  Gold nanoparticle-based simple colorimetric and ultrasensitive dynamic light scattering assay for the selective detection of Pb(II) from paints, plastics, and water samples. , 2011, ACS applied materials & interfaces.

[13]  Xin Zhang,et al.  Isomeric photoluminescent lead(II) coordination polymers based on designed pyridinecarboxylate ligands , 2011 .

[14]  A. Morsali,et al.  New reversible crystal-to-crystal conversion of a mixed-ligand lead(II) coordination polymer by de- and rehydration. , 2009, Inorganic chemistry.

[15]  Itamar Willner,et al.  A DNAzyme cascade for the amplified detection of Pb(2+) ions or L-histidine. , 2008, Chemical communications.

[16]  Jie-Sheng Chen,et al.  Structural variation from 1D to 3D: effects of ligands and solvents on the construction of lead(II)-organic coordination polymers. , 2007, Chemistry.

[17]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[18]  R. Zucali,et al.  Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.